Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
出版年份 2017 全文链接
标题
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-08-22
DOI
10.3389/fmicb.2017.01592
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs
- (2017) Amy Huei-Yi Lee et al. GENOME RESEARCH
- Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection
- (2017) Valerie Waters et al. Journal of Cystic Fibrosis
- Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
- (2017) Vidya P. Narayanaswamy et al. PLoS One
- Synthesis and antimicrobial properties of 4-acylaminobenzenethiosulfoacid S-esters
- (2017) Vira Lubenets et al. SAUDI PHARMACEUTICAL JOURNAL
- Cystic fibrosis physicians’ perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States
- (2017) Kathleen J. Ramos et al. BMC Pulmonary Medicine
- Volcanic Soils as Sources of Novel CO-Oxidizing Paraburkholderia and Burkholderia: Paraburkholderia hiiakae sp. nov., Paraburkholderia metrosideri sp. nov., Paraburkholderia paradisi sp. nov., Paraburkholderia peleae sp. nov., and Burkholderia alpina sp. nov. a Member of the Burkholderia cepacia Complex
- (2017) Carolyn F. Weber et al. Frontiers in Microbiology
- Genomics Reveals a Unique Clone of Burkholderia cenocepacia Harboring an Actively Excising Novel Genomic Island
- (2017) Prashant P. Patil et al. Frontiers in Microbiology
- Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients
- (2017) Milka Malešević et al. Antimicrobial Resistance and Infection Control
- Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models
- (2017) Freija Van den Driessche et al. PLoS One
- Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
- (2016) Douglas Fraser-Pitt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia
- (2016) April S. Gislason et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
- (2016) Elizabeth L. Salsgiver et al. CHEST
- Survival after lung transplantation for cystic fibrosis in Sweden
- (2016) Marita Gilljam et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Fish oils againstBurkholderiaandPseudomonas aeruginosa:in vitroefficacy and their therapeutic and prophylactic effects on infectedGalleria mellonellalarvae
- (2016) D. Mil-Homens et al. JOURNAL OF APPLIED MICROBIOLOGY
- Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States
- (2016) Kathleen J. Ramos et al. Journal of Cystic Fibrosis
- Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- (2016) Chi B. Vu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo
- (2016) Viola C. Scoffone et al. Scientific Reports
- Destruction of Opportunistic Pathogens via Polymer Nanoparticle-Mediated Release of Plant-Based Antimicrobial Payloads
- (2016) Dahlia N. Amato et al. Advanced Healthcare Materials
- Candidate Essential Genes in Burkholderia cenocepacia J2315 Identified by Genome-Wide TraDIS
- (2016) Yee-Chin Wong et al. Frontiers in Microbiology
- Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil
- (2016) Kuan Shion Ong et al. Frontiers in Microbiology
- Lung transplantation for cystic fibrosis: an update
- (2016) Cecilia Chaparro et al. Expert Review of Respiratory Medicine
- Cell Wall Recycling-Linked Coregulation of AmpC and PenB β-Lactamases throughampDMutations in Burkholderia cenocepacia
- (2015) Junghyun Hwang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms
- (2015) Sarah Kennedy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of fish oils on the outcomes of a mouse model of acute Pseudomonas aeruginosa pulmonary infection
- (2015) Emilie Caron et al. BRITISH JOURNAL OF NUTRITION
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical andin vitroevidence for the antimicrobial therapy inBurkholderia cepaciacomplex infections
- (2015) Vikas Gautam et al. Expert Review of Anti-Infective Therapy
- Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources
- (2015) Birgit De Smet et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia
- (2015) Viola C. Scoffone et al. Frontiers in Microbiology
- Mechanism of Resistance to an Antitubercular 2-Thiopyridine Derivative That Is Also Active against Burkholderia cenocepacia
- (2014) Viola C. Scoffone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells
- (2014) Silvia Buroni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections
- (2014) Diana D. Semler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity
- (2014) Fatima Kamal et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis Machinery
- (2014) Hongbaek Cho et al. CELL
- Exploring the Anti-Burkholderia cepaciaComplex Activity of Essential Oils: A Preliminary Analysis
- (2014) Isabel Maida et al. Evidence-based Complementary and Alternative Medicine
- Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
- (2014) Lisa Saiman et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The β-Lactamase Gene Regulator AmpR Is a Tetramer That Recognizes and Binds the d-Ala-d-Ala Motif of Its Repressor UDP-N-acetylmuramic Acid (MurNAc)-pentapeptide
- (2014) Grishma Vadlamani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of a Multiple-Locus Variable-Number Tandem-Repeat Typing Scheme for Genetic Fingerprinting of Burkholderia cenocepacia and Application to Nationwide Epidemiological Analysis
- (2014) Christine Segonds et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Catalytic Spectrum of the Penicillin-Binding Protein 4 of Pseudomonas aeruginosa, a Nexus for the Induction of β-Lactam Antibiotic Resistance
- (2014) Mijoon Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- IFN-γ Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages
- (2014) Kaivon Assani et al. PLoS One
- The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity
- (2014) Sung-Pin Tseng et al. PLoS One
- Environmental Heterogeneity Drives Within-Host Diversification and Evolution of Pseudomonas aeruginosa
- (2014) T. Markussen et al. mBio
- Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
- (2014) César de la Fuente-Núñez et al. PLoS Pathogens
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- Involvement of toxin-antitoxin modules inBurkholderia cenocepaciabiofilm persistence
- (2014) Heleen Van Acker et al. Pathogens and Disease
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
- (2013) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Respiratory bacterial infections in cystic fibrosis
- (2013) Oana Ciofu et al. CURRENT OPINION IN PULMONARY MEDICINE
- SNaPBcen: a Novel and Practical Tool for Genotyping Burkholderia cenocepacia
- (2013) N. Eusebio et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients
- (2013) Klara Dedeckova et al. Journal of Cystic Fibrosis
- Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: A placebo-controlled trial
- (2013) D. Elizabeth Tullis et al. Journal of Cystic Fibrosis
- An in vitro study of alginate oligomer therapies on oral biofilms
- (2013) J.L. Roberts et al. JOURNAL OF DENTISTRY
- The Use of Doripenem in Pediatric Cystic Fibrosis Patients in Case of Meropenem Shortages
- (2013) Jeffery T. Zobell et al. PEDIATRIC PULMONOLOGY
- Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species
- (2013) Heleen Van Acker et al. PLoS One
- Bacterial Persistence and Toxin-Antitoxin Loci
- (2012) Kenn Gerdes et al. Annual Review of Microbiology
- Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics
- (2012) Saira Khan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones
- (2012) Gilles Brackman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Importance of Rhamnolipid-Biosurfactant-Induced Changes in Bacterial Membrane Lipids of Bacillus subtilis for the Antimicrobial Activity of Thiosulfonates
- (2012) Anna Sotirova et al. CURRENT MICROBIOLOGY
- WS5.4 Aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species (BURK) infection: final results from a randomized, placebo-controlled trial
- (2012) E. Tullis et al. Journal of Cystic Fibrosis
- Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids
- (2012) Francis J. Gilchrist et al. Journal of Cystic Fibrosis
- Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance inBurkholderia cenocepacia†
- (2012) Mohamad A. Hamad et al. MOLECULAR MICROBIOLOGY
- A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS
- (2012) Xiaoxue Wang et al. Nature Chemical Biology
- Turning a new phage
- (2012) Lauren Gravitz NATURE MEDICINE
- Antimicrobial Polymers in Solution and on Surfaces: Overview and Functional Principles
- (2012) Felix Siedenbiedel et al. Polymers
- Host Evasion by Burkholderia cenocepacia
- (2012) Shyamala Ganesan et al. Frontiers in Cellular and Infection Microbiology
- Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms
- (2011) Tom Coenye et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AHL-dependent quorum sensing inhibition: Synthesis and biological evaluation of α-(N-alkyl-carboxamide)-γ-butyrolactones and α-(N-alkyl-sulfonamide)-γ-butyrolactones
- (2011) Mohamed Boukraa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BIGSdb: Scalable analysis of bacterial genome variation at the population level
- (2011) Keith A Jolley et al. BMC BIOINFORMATICS
- Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis
- (2011) Andrea Sass et al. BMC GENOMICS
- Heterogeneous bacterial persisters and engineering approaches to eliminate them
- (2011) Kyle R Allison et al. CURRENT OPINION IN MICROBIOLOGY
- The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia
- (2011) Dalila Mil-Homens et al. FEMS MICROBIOLOGY LETTERS
- Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives
- (2011) Anne-Sophie Messiaen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- (n-3) Long-Chain PUFA Differentially Affect Resistance to Pseudomonas aeruginosa Infection of Male and Female cftr–/– Mice
- (2011) Hélène Tiesset et al. JOURNAL OF NUTRITION
- Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes
- (2011) Tami D Lieberman et al. NATURE GENETICS
- Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia
- (2011) Silvia Bazzini et al. PLoS One
- Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy
- (2011) Nuno P. Mira et al. PLoS One
- Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
- (2011) Slade A. Loutet et al. Frontiers in Microbiology
- Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria
- (2010) Karen Bush et al. Annual Review of Microbiology
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- La suplementación con ácidos grasos mejora parámetros respiratorios, inflamatorios y nutricionales en adultos con fibrosis quística
- (2010) Gabriel Olveira et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Antimicrobial β-Peptides and α-Peptoids
- (2010) Troels Godballe et al. Chemical Biology & Drug Design
- Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
- (2010) P. Drevinek et al. CLINICAL MICROBIOLOGY AND INFECTION
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- A Decade of Burkholderia cenocepacia Virulence Determinant Research
- (2010) S. A. Loutet et al. INFECTION AND IMMUNITY
- Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis
- (2010) L. R. Mulcahy et al. JOURNAL OF BACTERIOLOGY
- Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience
- (2010) Anthony De Soyza et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- A two-tier model of polymyxin B resistance in Burkholderia cenocepacia
- (2010) Slade A. Loutet et al. Environmental Microbiology Reports
- Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential
- (2009) Andrew P. Desbois et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance
- (2009) Silvia Buroni et al. BMC MICROBIOLOGY
- Biosynthesis and Structure of theBurkholderia cenocepaciaK56-2 Lipopolysaccharide Core Oligosaccharide
- (2009) Ximena Ortega et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxidative Stress ofBurkholderia cenocepaciaInduces Insertion Sequence-Mediated Genomic Rearrangements That Interfere with Macrorestriction-Based Genotyping
- (2009) Pavel Drevinek et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Expanded Multilocus Sequence Typing for Burkholderia Species
- (2009) T. Spilker et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Impact ofBurkholderiaInfection on Lung Transplantation in Cystic Fibrosis
- (2008) Susan Murray et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Survival After Lung Transplantation of Cystic Fibrosis Patients Infected with Burkholderia cepacia Complex
- (2008) B. D. Alexander et al. AMERICAN JOURNAL OF TRANSPLANTATION
- (p)ppGpp: Still Magical?
- (2008) Katarzyna Potrykus et al. Annual Review of Microbiology
- Naturally Occurring Class A ss-Lactamases from the Burkholderia cepacia Complex
- (2008) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Burkholderia Genome Database: facilitating flexible queries and comparative analyses
- (2008) G. L. Winsor et al. BIOINFORMATICS
- Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
- (2008) J. Overhage et al. INFECTION AND IMMUNITY
- Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence
- (2008) Sophia G. Avgeri et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex
- (2008) E. Vanlaere et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
- (2008) M. T. G. Holden et al. JOURNAL OF BACTERIOLOGY
- Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy
- (2008) A. Weidmann et al. Journal of Cystic Fibrosis
- The prevalence of cystic fibrosis in the European Union
- (2008) Philip M. Farrell Journal of Cystic Fibrosis
- Dietary (n-3) Polyunsaturated Fatty Acids Affect the Kinetics of Pro- and Antiinflammatory Responses in Mice with Pseudomonas aeruginosa Lung Infection
- (2008) Hélène Tiesset et al. JOURNAL OF NUTRITION
- Inhibitors and antagonists of bacterial quorum sensing
- (2008) Nanting Ni et al. MEDICINAL RESEARCH REVIEWS
- Biological effects of essential oils – A review
- (2007) F. Bakkali et al. FOOD AND CHEMICAL TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started